Keywords: Pfizer, Wyeth, R&D site closures, Cost-cutting

Pfizer to close six global R&D sites as part of post-Wyeth acquisition cost-cutting

Article | 10 November 2009

Print This

Coming within a few weeks of the completion of its $68 billion buy-out of Wyeth, global number one drugmaker Pfizer has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in